Literature DB >> 25032095

Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Christopher S Kovacs1, Christine E Koval1, David van Duin1, Amanda Guedes de Morais1, Blanca E Gonzalez1, Robin K Avery1, Steven D Mawhorter1, Kyle D Brizendine1, Eric D Cober1, Cyndee Miranda1, Rabin K Shrestha1, Lucileia Teixeira1, Sherif B Mossad1.   

Abstract

Selection of the appropriate donor is essential to a successful allograft recipient outcome for solid organ transplantation. Multiple infectious diseases have been transmitted from the donor to the recipient via transplantation. Donor-transmitted infections cause increased morbidity and mortality to the recipient. In recent years, a series of high-profile transmissions of infections have occurred in organ recipients prompting increased attention on the process of improving the selection of an appropriate donor that balances the shortage of needed allografts with an approach that mitigates the risk of donor-transmitted infection to the recipient. Important advances focused on improving donor screening diagnostics, using previously excluded high-risk donors, and individualizing the selection of allografts to recipients based on their prior infection history are serving to increase the donor pool and improve outcomes after transplant. This article serves to review the relevant literature surrounding this topic and to provide a suggested approach to the selection of an appropriate solid organ transplant donor.

Entities:  

Keywords:  Donor selection; Infection; Mass screening; Transplantation; Treatment outcome

Year:  2014        PMID: 25032095      PMCID: PMC4094952          DOI: 10.5500/wjt.v4.i2.43

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  153 in total

1.  Highly resistant bacteria and donor-derived infections: treading in uncharted territory.

Authors:  C D Sifri; M G Ison
Journal:  Transpl Infect Dis       Date:  2012-06       Impact factor: 2.228

2.  Transmission of lymphocytic choriomeningitis virus by organ transplantation.

Authors:  Staci A Fischer; Mary Beth Graham; Matthew J Kuehnert; Camille N Kotton; Arjun Srinivasan; Francisco M Marty; James A Comer; Jeannette Guarner; Christopher D Paddock; Dawn L DeMeo; Wun-Ju Shieh; Bobbie R Erickson; Utpala Bandy; Alfred DeMaria; Jeffrey P Davis; Francis L Delmonico; Boris Pavlin; Anna Likos; Martin J Vincent; Tara K Sealy; Cynthia S Goldsmith; Daniel B Jernigan; Pierre E Rollin; Michelle M Packard; Mitesh Patel; Courtney Rowland; Rita F Helfand; Stuart T Nichol; Jay A Fishman; Thomas Ksiazek; Sherif R Zaki
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

3.  The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.

Authors:  Ioanna Delladetsima; Mina Psichogiou; Vana Sypsa; Erasmia Psimenou; Alkiviadis Kostakis; Angelos Hatzakis; John N Boletis
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

4.  Guidance on novel influenza A/H1N1 in solid organ transplant recipients.

Authors:  D Kumar; M I Morris; C N Kotton; S A Fischer; M G Michaels; U Allen; E A Blumberg; M Green; A Humar; M G Ison
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

Review 5.  An update on donor-derived disease transmission in organ transplantation.

Authors:  M G Ison; M A Nalesnik
Journal:  Am J Transplant       Date:  2011-03-28       Impact factor: 8.086

6.  Donor-transmitted malignancies in organ transplantation: assessment of clinical risk.

Authors:  M A Nalesnik; E S Woodle; J M Dimaio; B Vasudev; L W Teperman; S Covington; S Taranto; J P Gockerman; R Shapiro; V Sharma; L J Swinnen; A Yoshida; M G Ison
Journal:  Am J Transplant       Date:  2011-06       Impact factor: 8.086

7.  Donor-derived fungal infections in organ transplant recipients: guidelines of the American Society of Transplantation, infectious diseases community of practice.

Authors:  N Singh; S Huprikar; S D Burdette; M I Morris; J E Blair; L J Wheat
Journal:  Am J Transplant       Date:  2012-06-13       Impact factor: 8.086

8.  Outcome of renal transplantation in eight patients with Candida sp. contamination of preservation fluid.

Authors:  M Matignon; F Botterel; V Audard; B Dunogue; K Dahan; P Lang; S Bretagne; P Grimbert
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

9.  Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor.

Authors:  R T Chung; S Feng; F L Delmonico
Journal:  Am J Transplant       Date:  2001-07       Impact factor: 8.086

Review 10.  Use of hepatitis B core antibody-positive donors for liver transplantation.

Authors:  Santiago J Muñoz
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

View more
  7 in total

1.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

2.  Antibiotic therapy in case of positive cultures of kidney transplant preservation fluid: a nationwide survey of prescribing practices.

Authors:  N Le Berre; M Ladrière; A Corbel; T Remen; L Durin; L Frimat; N Thilly; C Pulcini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-04       Impact factor: 3.267

3.  Potential yield of imminent death kidney donation.

Authors:  Ryan A Denu; Eneida A Mendonca; Norman Fost
Journal:  Am J Transplant       Date:  2017-11-11       Impact factor: 8.086

4.  Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.

Authors:  Alessandra Oliva; Alessia Cipolla; Francesca Gizzi; Alessandra D'Abramo; Marco Favaro; Massimiliano De Angelis; Giancarlo Ferretti; Gianluca Russo; Marco Iannetta; Claudio M Mastroianni; Maria T Mascellino; Vincenzo Vullo
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

5.  Clinical Vignettes: Donor-Derived Infections.

Authors:  Tanvi S Sharma; Marian G Michaels; Lara Danziger-Isakov; Betsy C Herold
Journal:  J Pediatric Infect Dis Soc       Date:  2018-12-26       Impact factor: 3.164

Review 6.  Diverse Routes of Allograft Tolerance Disruption by Memory T Cells.

Authors:  Ronald G Gill; Adam L Burrack
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

7.  Candida Contamination in Kidney and Liver Organ Preservation Solution: Does It Matter?

Authors:  Sabrina Stern; Dmitri Bezinover; Peter-M Rath; Andreas Paul; Fuat H Saner
Journal:  J Clin Med       Date:  2021-05-09       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.